Newly Diagnosed Oral Cancer Stage and Time from Diagnosis to Treatment in the Pre-COVID-19 and Early COVID-19 Periods: A Nationwide Cohort Study

Background: During the COVID-19 pandemic, patients’ willingness to seek medical attention decreased. Patients with precancerous lesions may have missed out on opportunities for early detection. This affected the time to the initiation of treatment for patients with oral cancer. This study examined whether patients with oral cancer were less likely to be at early cancer stages and analyzed whether the time from the diagnosis to the initiation of treatment was delayed during the pandemic. Methods: This retrospective study analyzed data from the Taiwan National Health Insurance Research Database, Cancer Registry File, and Multiple Cause of Death File. Patients who received new diagnoses of oral cancer were divided into a pre-COVID-19 group (2018) and an early COVID-19 group (2020). Propensity score matching was performed between the two cohorts. Conditional logistic regression analyses were conducted to evaluate the risks of an early-stage oral cancer diagnosis and treatment delay from diagnosis to treatment initiation in the two periods. Results: The odds ratio (OR) for early cancer staging among patients with oral cancer in the early COVID-19 period was 0.89 (95% CI: 0.82–0.96) compared to the pre-COVID-19 period. The OR for delayed treatment among patients with oral cancer in the early COVID-19 period compared with that in the pre-COVID-19 period was 0.95 (95% CI: 0.86–1.05; p = 0.337). Conclusions: The early COVID-19 period was associated with a higher risk of advanced cancer staging, and we did not find a significant association with a delay in the initiation of treatment among patients with oral cancer in Taiwan.

Authors

Institutions

Publication Details

Journal
Healthcare
Published
2026-11-13
DOI
https://doi.org/10.3390/healthcare14223891
Primary Topic
COVID-19 and healthcare impacts
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Newly Diagnosed Oral Cancer Stage and Time from Diagnosis to Treatment in the Pre-COVID-19 and Early COVID-19 Periods: A Nationwide Cohort Study

Wen‐Chen Tsai, Wei-Yin Kuo, Pei‐Tseng Kung, You-Chen Lin et al.
1 links
Healthcare
COVID-19 and healthcare impacts
article

Newly Diagnosed Oral Cancer Stage and Time from Diagnosis to Treatment in the Pre-COVID-19 and Early COVID-19 Periods: A Nationwide Cohort Study

Wen‐Chen Tsai, Wei-Yin Kuo, Pei‐Tseng Kung, You-Chen Lin, Ta-Jen Liu
article en

Abstract

Background: During the COVID-19 pandemic, patients’ willingness to seek medical attention decreased. Patients with precancerous lesions may have missed out on opportunities for early detection. This affected the time to the initiation of treatment for patients with oral cancer. This study examined whether patients with oral cancer were less likely to be at early cancer stages and analyzed whether the time from the diagnosis to the initiation of treatment was delayed during the pandemic. Methods: This retrospective study analyzed data from the Taiwan National Health Insurance Research Database, Cancer Registry File, and Multiple Cause of Death File. Patients who received new diagnoses of oral cancer were divided into a pre-COVID-19 group (2018) and an early COVID-19 group (2020). Propensity score matching was performed between the two cohorts. Conditional logistic regression analyses were conducted to evaluate the risks of an early-stage oral cancer diagnosis and treatment delay from diagnosis to treatment initiation in the two periods. Results: The odds ratio (OR) for early cancer staging among patients with oral cancer in the early COVID-19 period was 0.89 (95% CI: 0.82–0.96) compared to the pre-COVID-19 period. The OR for delayed treatment among patients with oral cancer in the early COVID-19 period compared with that in the pre-COVID-19 period was 0.95 (95% CI: 0.86–1.05; p = 0.337). Conclusions: The early COVID-19 period was associated with a higher risk of advanced cancer staging, and we did not find a significant association with a delay in the initiation of treatment among patients with oral cancer in Taiwan.

HealthcareVol. 14(22)
Asia University (TW), China Medical University (TW), Chung Shan Medical University Hospital (TW), Saint Mary's Hospital Luodong (TW), Chung Shan Medical University (TW)
Good health and well-being
COVID-19 and healthcare impacts
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon